Feb. 8, 2021
The South Carolina Chapter of The Leukemia & Lymphoma Society (LLS) has announced that Cory Manning, a partner in Nelson Mullins Riley & Scarborough LLP’s Columbia office, will serve as the corporate walk chair of its 2021 Light The Night®, LLS’s annual fundraising event held each fall to find cures and provide access to treatments for blood cancer patients. The corporate walk chair will lead the effort in accelerating corporate support and driving revenue growth for Light The Night to support LLS’s ultimate goal of creating a world without blood cancers.
Coming together for a common goal, friends, family, and co-workers form fundraising walk teams in support of Light The Night and LLS research funding. Millions of consumers also help by donating at retail outlets. Culminating in inspirational and memorable evening walks every fall, participants in 140 communities across North America join together carrying illuminated lanterns to take steps to end cancer – white for survivors, red for supporters, and gold in memory of loved ones lost to cancer.
“I am honored to serve as the corporate walk chair and look forward to encouraging local businesses and corporations to join me in supporting The Leukemia & Lymphoma Society by participating in Light The Night,” said Manning, LLS’s Light The Night Chair in Columbia. “Together, we are taking steps to end cancer.”
Manning practices in the areas of corporate internal and regulatory investigations, securities litigation, business litigation, and class action defense. He co-chairs Nelson Mullins’ White Collar Defense and Government Investigations Practice. He has been an LLS volunteer and participant in Light The Night since 2014.
This year, Light The Night will be held on Thursday, Nov. 4 at the South Carolina State House.
“When a loved one hears the words ‘you have cancer,’ it is one of the darkest moments in your life,” said Amanda Yancey, LLS executive director. “At Light The Night, it is our aim to bring light to the darkness of cancer through research and cures and reinforce the urgent need to raise awareness. LLS is a global leader in the fight against cancer, and we won’t stop until we achieve a world without blood cancer.”
LLS was founded by a family for families, years ago at a time when a diagnosis of leukemia was nearly 100% fatal. Now, with the development of new treatments for childhood leukemia, to today’s advances in precision medicine and immunotherapy, LLS has had a colossal impact on advancing cancer cures and changing the way cancer is treated and the care for patients.
Through its efforts, it has invested nearly $1.3 billion in cutting-edge research to advance therapies. Thanks to research, survival rates for patients with many blood cancers have doubled, tripled, and even quadrupled since the early 1960s, according to the organization. Yet, despite these advances, about one-third of patients with blood cancer still do not survive even five years after their diagnosis.
To form a team or to learn more, please call the Georgia/South Carolina Office at (404) 720-7900 or visit www.lightthenight.org.
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society® is a global leader in the fight against cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease, and myeloma and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.
Founded in 1949 and headquartered in Rye Brook, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m. ET.
For additional information, visit lls.org/lls-newsnetwork.
Established in 1897, Nelson Mullins has more than 850 attorneys and government relations professionals with offices in 11 states and Washington, DC. For more information on the firm, go to www.nelsonmullins.com.
These materials have been prepared for informational purposes only and are not legal advice. This information is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Internet subscribers and online readers should not act upon this information without seeking professional counsel.